Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.580
Filtrar
Más filtros

Intervalo de año de publicación
1.
Cell Tissue Res ; 380(3): 565-579, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32043208

RESUMEN

The RNASET2 ribonuclease, belonging to the highly conserved RH/T2/s RNase gene family, has been recently shown to modulate inflammatory processes in both vertebrates and invertebrates. Indeed, the RNASET2 protein acts as a chemoattractor for macrophages in both in vitro and in vivo experimental settings and its expression significantly increases following bacterial infections. Moreover, we recently observed that injection of human recombinant RNASET2 protein in the body wall of the medicinal leech (a consolidated invertebrate model for both immune response and tissue regeneration) not only induced immune cell recruitment but also apparently triggered massive connective tissue remodelling as well. Based on these data, we evaluate here a possible role of leech recombinant RNASET2 protein (rHvRNASET2) in connective tissue remodelling by characterizing the cell types involved in this process through histochemical, morphological and immunofluorescent assays. Moreover, a time-course expression analysis of newly synthesized pro-collagen1α1 (COL1α1) and basic FGF receptor (bFGFR, a known fibroblast marker) following rHvRNASET2 injection in the leech body wall further supported the occurrence of rHvRNASET2-mediated matrix remodelling. Human MRC-5 fibroblast cells were also investigated in order to evaluate their pattern of collagen neosynthesis driven by rHvRNASET2 injection.Taken together, the data reported in this work provide compelling evidence in support of a pleiotropic role for RNASET2 in orchestrating an evolutionarily conserved crosstalk between inflammatory response and regenerative process, based on macrophage recruitment and fibroblast activation, coupled to a massive extracellular reorganization.


Asunto(s)
Colágeno Tipo I/metabolismo , Tejido Conectivo/efectos de los fármacos , Hirudo medicinalis/efectos de los fármacos , Receptor Tipo 1 de Factor de Crecimiento de Fibroblastos/metabolismo , Proteínas Recombinantes/farmacología , Ribonucleasas/farmacología , Animales , Línea Celular , Cadena alfa 1 del Colágeno Tipo I , Tejido Conectivo/fisiología , Fibroblastos/efectos de los fármacos , Humanos
2.
Bull Exp Biol Med ; 167(1): 47-49, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-31177448

RESUMEN

We studied the influence of synthetic indolicidin analogues on the development of acute periodontitis. The corrective effect was found in indolicidin analogues Nos. 7 and 8; it manifested in a decrease in the edema of gingival epithelium and lamina propria, a decrease in the relative area of inflammatory infiltrates, and a significant increase in the relative area of normal connective tissue. These changes were revealed as soon as on day 14 and were most pronounced in 21 days after the removal of the ligature. Indolicidin analogues Nos. 7 and 8 demonstrated similar effectiveness on the model of acute periodontitis.


Asunto(s)
Péptidos Catiónicos Antimicrobianos/uso terapéutico , Periodontitis/tratamiento farmacológico , Animales , Péptidos Catiónicos Antimicrobianos/química , Tejido Conectivo/efectos de los fármacos , Tejido Conectivo/metabolismo , Encía/citología , Encía/metabolismo , Membrana Mucosa/efectos de los fármacos , Membrana Mucosa/metabolismo , Ratas Wistar
3.
Br J Dermatol ; 178(5): 1011-1019, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29086923

RESUMEN

There is growing evidence that botulinum neurotoxins (BoNTs) exhibit biological effects on various human cell types with a host of associated clinical implications. This review aims to provide an update on the non-neuronal and nonmuscular effects of botulinum toxin. We critically analysed recent reports on the structure and function of cellular signalling systems subserving biological effects of BoNTs. The BoNT receptors and intracellular targets are not unique for neurotransmission. They have been found in both neuronal and non-neuronal cells, but there are differences in how BoNT binds to, and acts on, neuronal vs. non-neuronal cells. The non-neuronal cells that express one or more BoNT/A-binding proteins, and/or cleavage target synaptosomal-associated protein 25, include: epidermal keratinocytes; mesenchymal stem cells from subcutaneous adipose; nasal mucosal cells; urothelial cells; intestinal, prostate and alveolar epithelial cells; breast cell lines; neutrophils; and macrophages. Serotype BoNT/A can also elicit specific biological effects in dermal fibroblasts, sebocytes and vascular endothelial cells. Nontraditional applications of BoNT have been reported for the treatment of the following dermatological conditions: hyperhidrosis, Hailey-Hailey disease, Darier disease, inversed psoriasis, aquagenic palmoplantar keratoderma, pachyonychia congenita, multiple eccrine hydrocystomas, eccrine angiomatous hamartoma, eccrine sweat gland naevi, congenital eccrine naevus, Raynaud phenomenon and cutaneous leiomyomas. Experimental studies have demonstrated the ability of BoNT/A to protect skin flaps, facilitate wound healing, decrease thickness of hypertrophic scars, produce an anti-ageing effect, improve a mouse model of psoriasiform dermatitis, and have also revealed extracutaneous effects of BoNT arising from its anti-inflammatory and anticancer properties. BoNTs have a much wider range of applications than originally understood, and the individual cellular responses to the cholinergic impacts of BoNTs could provide fertile ground for future studies.


Asunto(s)
Toxinas Botulínicas Tipo A/farmacología , Fármacos Neuromusculares/farmacología , Neurotoxinas/farmacología , Enfermedades de la Piel/tratamiento farmacológico , Animales , Antiinflamatorios/farmacología , Antineoplásicos/farmacología , Células Cultivadas , Tejido Conectivo/efectos de los fármacos , Cosméticos/farmacología , Modelos Animales de Enfermedad , Humanos , Conejos , Ratas , Piel/irrigación sanguínea , Colgajos Quirúrgicos/irrigación sanguínea
4.
J Periodontal Res ; 53(2): 222-231, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29063626

RESUMEN

BACKGROUND AND OBJECTIVE: Nowadays, most designs for the transmucosal surface of implants are machined-smooth. However, connective tissue adhered to the smooth surface of an implant has poor mechanical resistance, which can render separation of tissue from the implant interface and induce epithelial downgrowth. Modification of the transmucosal surface of implants, which can help form a good seal of connective tissue, is therefore desired. We hypothesized that anodic oxidation (AO) and polydopamine (PD) deposition could be used to enhance the attachment between an implant and peri-implant connective tissue. We tested this hypothesis in the mandibles of Beagle dogs. MATERIAL AND METHODS: AO and PD were used to modify the transmucosal region of transmucosal implants (implant neck). The surface microstructure, surface roughness and elemental composition were investigated in vitro. L929 mouse fibroblasts were cultured to test the effect of PD on cell adhesion. Six Beagle dogs were used for the in vivo experiment (n = 6 dogs per group). Three months after building the edentulous animal model, four groups of implants (control, AO, PD and AO + PD) were inserted. After 4 months of healing, samples were harvested for histometric analyses. RESULTS: The surfaces of anodized implant necks were overlaid with densely distributed pores, 2-7 µm in size. On the PD-modified surfaces, N1s, the chemical bond of nitrogen in PD, was detected using X-ray photoelectron spectroscopy. L929 developed pseudopods more quickly on the PD-modified surfaces than on the surfaces of the control group. The in vivo experiment showed a longer connective tissue seal and a more coronally located peri-implant soft-tissue attachment in the AO + PD group than in the control group (P < .05). CONCLUSION: The modification of AO + PD on the implant neck yielded better attachment between the implant and peri-implant connective tissue.


Asunto(s)
Tejido Conectivo/efectos de los fármacos , Implantes Dentales , Diseño de Prótesis Dental , Inserción Epitelial/efectos de los fármacos , Indoles/farmacología , Polímeros/farmacología , Animales , Adhesión Celular/efectos de los fármacos , Materiales Biocompatibles Revestidos , Tejido Conectivo/patología , Implantación Dental Endoósea , Perros , Inserción Epitelial/patología , Fibroblastos/efectos de los fármacos , Mandíbula , Ratones , Modelos Animales , Oseointegración/efectos de los fármacos , Oxidación-Reducción , Propiedades de Superficie , Factores de Tiempo , Titanio
5.
J Biochem Mol Toxicol ; 32(2)2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29315975

RESUMEN

Rutin, naturally occurring flavonoid, has reported to cover interesting multiple pharmacological properties. This study evaluated rutin or/and meloxicam effects in paw inflammation induced by formalin in mice. Mice were divided into four groups: I-Formalin group, II-Rutin 60 mg/kg (p.o.), III-Meloxicam 10 mg/kg (p.o.), plus IV-Combined rutin and meloxicam. Therapies were administered once a day for 7 days. The curative effects were assessed on inflammatory, oxidative stress, and apoptosis. Both rutin and/or meloxicam induced marked improvement in paw licking time on the 1st day and by combined treatment only on the 3rd day as well reduction in paw edema% on the 3rd day. Moreover, noticeable progress in liver malondialdehyde content, superoxide dismutase, and sorbitol dehydrogenase activities as well decline in paw interleukin-1ß level and extent of apoptosis. The results spot light on the good influence of combined rutin and meloxicam in formalin-induced mice paw inflammation to a better extent than either rutin or meloxicam lonely.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Celulitis (Flemón)/tratamiento farmacológico , Tejido Conectivo/efectos de los fármacos , Modelos Animales de Enfermedad , Hígado/efectos de los fármacos , Rutina/uso terapéutico , Tiazinas/uso terapéutico , Tiazoles/uso terapéutico , Dolor Agudo/etiología , Dolor Agudo/inmunología , Dolor Agudo/prevención & control , Analgésicos no Narcóticos/uso terapéutico , Animales , Antiinflamatorios no Esteroideos/efectos adversos , Antioxidantes/efectos adversos , Antioxidantes/uso terapéutico , Apoptosis/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Celulitis (Flemón)/metabolismo , Celulitis (Flemón)/patología , Celulitis (Flemón)/fisiopatología , Tejido Conectivo/inmunología , Tejido Conectivo/metabolismo , Tejido Conectivo/patología , Quimioterapia Combinada , Edema/etiología , Edema/inmunología , Edema/prevención & control , L-Iditol 2-Deshidrogenasa/metabolismo , Hígado/inmunología , Hígado/metabolismo , Hígado/patología , Masculino , Meloxicam , Ratones , Tamaño de los Órganos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Distribución Aleatoria , Rutina/efectos adversos , Superóxido Dismutasa/metabolismo , Tiazinas/efectos adversos , Tiazoles/efectos adversos
6.
Int Endod J ; 51(6): 641-648, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29143348

RESUMEN

AIM: To investigate whether hypertension affects mineralization associated with white and grey mineral trioxide aggregate (MTA Angelus® ) implanted subcutaneously into rats by assaying osteoblastic biomarkers. METHODOLOGY: Polyethylene tubes containing grey MTA Angelus® , white MTA Angelus® , intermediate restorative material (IRM; positive control) or an empty tube (negative control) were implanted into the dorsal connective tissue of spontaneous hypertensive (n = 12) and Wistar (normotensive; n = 10) rats. Half of the rats in each group were killed after 7 days, and the remaining after 30 days. Tubes with surrounding tissue were removed, and immunostaining was performed to detect RUNX-2, OPN and OCN proteins. The normality of data was analysed using the Shapiro-Wilk test. Comparison of two independent groups was performed using the Mann-Whitney U-test, to detect a significant difference. A post hoc test accounting for multiple comparisons was performed following Tukey's test (P < 0.05). RESULTS: Under hypertensive conditions after 30 days, both MTA materials were associated with immunolabelling for RUNX-2 from low to moderate, which was less than that observed at normal blood pressure and the 7-day groups (P < 0.05). The expression of OPN and OCN proteins under both MTA conditions was considered low after both 7 and 30 days for the hypertensive condition, and was less than that in animals with normal blood pressure after 30 days (P < 0.05). No immunostaining for any biomarkers in the control and IRM groups was observed (P < 0.05). CONCLUSION: Hypertension decreased the immunostaining of RUNX-2, OPN and OCN biomarkers in response to MTA. Thus, hypertension can jeopardize the mineralization ability of MTA and may have a negative impact on endodontic treatment outcomes.


Asunto(s)
Compuestos de Aluminio/farmacología , Compuestos de Calcio/farmacología , Subunidad alfa 1 del Factor de Unión al Sitio Principal/metabolismo , Proteínas del Citoesqueleto/metabolismo , Proteínas Activadoras de GTPasa/metabolismo , Hipertensión/metabolismo , Proteínas Nucleares/metabolismo , Osteocalcina/metabolismo , Óxidos/farmacología , Materiales de Obturación del Conducto Radicular/farmacología , Silicatos/farmacología , Animales , Materiales Biocompatibles/farmacología , Biomarcadores/metabolismo , Tejido Conectivo/efectos de los fármacos , Combinación de Medicamentos , Ratas , Ratas Wistar
7.
Cell Tissue Res ; 368(2): 337-351, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28070637

RESUMEN

In recent years, several studies have demonstrated that the RNASET2 gene is involved in the control of tumorigenicity in ovarian cancer cells. Furthermore, a role in establishing a functional cross-talk between cancer cells and the surrounding tumor microenvironment has been unveiled for this gene, based on its ability to act as an inducer of the innate immune response. Although several studies have reported on the molecular features of RNASET2, the details on the mechanisms by which this evolutionarily conserved ribonuclease regulates the immune system are still poorly defined. In the effort to clarify this aspect, we report here the effect of recombinant human RNASET2 injection and its role in regulating the innate immune response after bacterial challenge in an invertebrate model, the medicinal leech. We found that recombinant RNASET2 injection induces fibroplasias, connective tissue remodeling and the recruitment of numerous infiltrating cells expressing the specific macrophage markers CD68 and HmAIF1. The RNASET2-mediated chemotactic activity for macrophages has been further confirmed by using a consolidated experimental approach based on injection of the Matrigel biomatrice (MG) supplemented with recombinant RNASET2 in the leech body wall. One week after injection, a large number of CD68+ and HmAIF-1+ macrophages massively infiltrated MG sponges. Finally, in leeches challenged with lipopolysaccharides (LPS) or with the environmental bacteria pathogen Micrococcus nishinomiyaensis, numerous macrophages migrating to the site of inoculation expressed high levels of endogenous RNASET2. Taken together, these results suggest that RNASET2 is likely involved in the initial phase of the inflammatory response in leeches.


Asunto(s)
Tejido Conectivo/patología , Hirudo medicinalis/fisiología , Inflamación/patología , Proteínas Recombinantes/farmacología , Ribonucleasas/farmacología , Proteínas Supresoras de Tumor/farmacología , Fosfatasa Ácida/metabolismo , Animales , Proliferación Celular/efectos de los fármacos , Colágeno/metabolismo , Tejido Conectivo/efectos de los fármacos , Crioultramicrotomía , Combinación de Medicamentos , Pruebas de Enzimas , Técnica del Anticuerpo Fluorescente , Hirudo medicinalis/anatomía & histología , Hirudo medicinalis/efectos de los fármacos , Hirudo medicinalis/ultraestructura , Humanos , Laminina/metabolismo , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Proteoglicanos/metabolismo
8.
Muscle Nerve ; 55(1): 128-130, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27603578

RESUMEN

INTRODUCTION: In this study we investigated the impact of whey protein hydrolysate and maltodextrin (WPH) intake on intramuscular connective tissue (IMCT) protein fractional synthesis rate (FSR) after maximal shortening and lengthening contractions. METHODS: Twenty young men were randomized to receive either WPH or maltodextrin [carbohydrate (CHO)] immediately after completion of unilateral shortening and lengthening knee extensions. Ring-13 C6 -phenylalanine was infused, and muscle biopsies were obtained. IMCT protein FSR was measured at 1-5, as well as 1-3 and 3-5 hours after contractions and nutrient intake. RESULTS: During the 1-3-hour recovery, lengthening contractions resulted in a higher FSR than shortening contractions (P < 0.01), independent of supplementation type and, during the 3-5-hour recovery, WPH had a higher FSR than CHO (P < 0.05), independent of prior contraction mode. CONCLUSIONS: The later appearance of a stimulating effect of WPH on the IMCT FSR after strenuous muscle contractions lends support to its ability to promote recovery of the muscle connective tissue matrix after exercise. Muscle Nerve 55: 128-130, 2017.


Asunto(s)
Tejido Conectivo/efectos de los fármacos , Tejido Conectivo/metabolismo , Músculo Esquelético/citología , Polisacáridos/farmacología , Proteína de Suero de Leche/biosíntesis , Adulto , Análisis de Varianza , Lateralidad Funcional , Humanos , Masculino , Contracción Muscular/fisiología , Proteínas Musculares/metabolismo , Fenilalanina , Proteína de Suero de Leche/metabolismo , Adulto Joven
9.
Biochim Biophys Acta Gen Subj ; 1861(2): 135-146, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27865997

RESUMEN

BACKGROUND: Alkaptonuria (AKU) is an ultra-rare inborn error of metabolism characterized by homogentisic acid (HGA) accumulation due to a deficient activity of the homogentisate 1.2-dioxygenase (HGD) enzyme. This leads to the production of dark pigments that are deposited onto connective tissues, a condition named 'ochronosis' and whose mechanisms are not completely clear. Recently, the potential role of hitherto unidentified proteins in the ochronotic process was hypothesized, and the presence of Serum Amyloid A (SAA) in alkaptonuric tissues was reported, allowing the classification of AKU as a novel secondary amyloidosis. METHODS: Gel electrophoresis, Western Blot, Congo Red-based assays and electron microscopy were used to investigate the effects of HGA on the aggregation and fibrillation propensity of amyloidogenic proteins and peptides [Aß(1-42), transthyretin, atrial natriuretic peptide, α-synuclein and SAA]. LC/MS and in silico analyses were undertaken to identify possible binding sites for HGA (or its oxidative metabolite, a benzoquinone acetate or BQA) in SAA. RESULTS: We found that HGA might act as an amyloid aggregation enhancer in vitro for all the tested proteins and peptides in a time- and dose- dependent fashion, and identified a small crevice at the interface between two HGD subunits as a candidate binding site for HGA/BQA. CONCLUSIONS: HGA might be an important amyloid co- component playing significant roles in AKU amyloidosis. GENERAL SIGNIFICANCE: Our results provide a possible explanation for the clinically verified onset of amyloidotic processes in AKU and might lay the basis to setup proper pharmacological approaches to alkaptonuric ochronosis, which are still lacking.


Asunto(s)
Proteínas Amiloidogénicas/metabolismo , Ácido Homogentísico/farmacología , Agregación Patológica de Proteínas/inducido químicamente , Alcaptonuria/metabolismo , Péptidos beta-Amiloides/metabolismo , Amiloidosis/metabolismo , Factor Natriurético Atrial/metabolismo , Sitios de Unión/efectos de los fármacos , Tejido Conectivo/efectos de los fármacos , Tejido Conectivo/metabolismo , Homogentisato 1,2-Dioxigenasa/metabolismo , Humanos , Ocronosis/metabolismo , Oxidación-Reducción/efectos de los fármacos , Prealbúmina/metabolismo , Proteína Amiloide A Sérica/metabolismo , alfa-Sinucleína/metabolismo
10.
J Surg Res ; 207: 102-107, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27979464

RESUMEN

BACKGROUND: There are over two million laparotomies performed in the United States each year with an incisional hernia rate between 2% and 11%. A total of 100,000 ventral hernia repairs are undertaken each year with recurrences as high as 50%. MATERIALS AND METHODS: Full thickness midline fascia incisions from the xiphoid to the pubic symphysis were made in rats. The fascia and/or muscular layer was sutured closed and a gel with 300 µM of sodium orthovanadate or saline was placed over the suture line with the skin closed over it. On day 10, 1-cm strips from the superior, middle, and inferior regions of the abdominal wall were tested for breaking strength and processed for histology. RESULTS: The mean wound breaking strength of vanadate-treated wounds was 18.6 ± 2.7 N compared with 9.4 ± 3.6 N for controls (P < 0.0001). Similar quantities of granulation tissue were deposited in treated and control wounds. Fine green birefringence patterns, characteristic of immature connective tissue, were seen in control samples viewed with polarized light. In contrast, vanadate-treated wounds showed thick yellow-orange birefringence patterns characteristics of more mature connective tissue. Using α-smooth muscle actin immunostaining, myofibroblasts were prominent in control incisions, but few were identified in vanadate-treated incisions. CONCLUSIONS: In rat laparotomy wounds, a single application of vanadate increases wound breaking strength, through enhanced connective tissue organization. These combined data suggest topical application of vanadate immediately after fascial closure will increase wound strength, possibly reducing hernia recurrences in the repaired abdominal wall.


Asunto(s)
Técnicas de Cierre de Herida Abdominal , Inhibidores Enzimáticos/uso terapéutico , Hernia Incisional/prevención & control , Laparotomía , Herida Quirúrgica/tratamiento farmacológico , Vanadatos/uso terapéutico , Administración Tópica , Animales , Fenómenos Biomecánicos , Tejido Conectivo/efectos de los fármacos , Tejido Conectivo/fisiología , Inhibidores Enzimáticos/farmacología , Femenino , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Herida Quirúrgica/fisiopatología , Resistencia a la Tracción/efectos de los fármacos , Resultado del Tratamiento , Vanadatos/farmacología , Cicatrización de Heridas/efectos de los fármacos , Cicatrización de Heridas/fisiología
11.
J Periodontal Res ; 52(2): 186-200, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27038334

RESUMEN

BACKGROUND AND OBJECTIVE: Periodontal disease is the most common chronic inflammatory disease known to mankind (and the major cause of tooth loss in the adult population) and has also been linked to various systemic diseases, particularly diabetes mellitus. Based on the literature linking periodontal disease with diabetes in a "bidirectional manner", the objectives of the current study were to determine: (i) the effect of a model of periodontitis, complicated by diabetes, on mechanisms of tissue breakdown including bone loss; and (ii) the response of the combination of this local and systemic phenotype to a novel pleiotropic matrix metalloproteinase inhibitor, chemically modified curcumin (CMC) 2.24. MATERIAL AND METHODS: Diabetes was induced in adult male rats by intravenous injection of streptozotocin (nondiabetic rats served as controls), and Escherichia coli endotoxin (lipopolysaccharide) was repeatedly injected into the gingiva to induce periodontitis. CMC 2.24 was administered by oral gavage (30 mg/kg) daily; untreated diabetic rats received vehicle alone. After 3 wk of treatment, the rats were killed, and gingiva, jaws, tibia and skin were collected. The maxillary jaws and tibia were dissected and radiographed. The gingival tissues of each experimental group (n = 6 rats/group) were pooled, extracted, partially purified and, together with individual skin samples, analyzed for matrix metalloproteinase (MMP)-2 and MMP-9 by gelatin zymography; MMP-8 was analyzed in gingival and skin tissue extracts, and in serum, by western blotting. The levels of three bone-resorptive cytokines [interleukin (IL)-1ß, IL-6 and tumor necrosis factor-α], were measured in gingival tissue extracts and serum by ELISA. RESULTS: Systemic administration of CMC 2.24 to diabetic rats with endotoxin-induced periodontitis significantly inhibited alveolar bone loss and attenuated the severity of local and systemic inflammation. Moreover, this novel tri-ketonic phenylaminocarbonyl curcumin (CMC 2.24) appeared to reduce the pathologically excessive levels of inducible MMPs to near-normal levels, but appeared to have no significant effect on the constitutive MMPs required for physiologic connective tissue turnover. In addition to the beneficial effects on periodontal disease, induced both locally and systemically, CMC 2.24 also favorably affected extra-oral connective tissues, skin and skeletal bone. CONCLUSION: This study supports our hypothesis that CMC 2.24 is a potential therapeutic pleiotropic MMP inhibitor, with both intracellular and extracellular effects, which reduces local and systemic inflammation and prevents hyperglycemia- and bacteria-induced connective tissue destruction.


Asunto(s)
Antiinflamatorios/uso terapéutico , Tejido Conectivo/efectos de los fármacos , Curcumina/análogos & derivados , Diabetes Mellitus Experimental/tratamiento farmacológico , Inflamación/tratamiento farmacológico , Periodontitis/tratamiento farmacológico , Proceso Alveolar/efectos de los fármacos , Proceso Alveolar/metabolismo , Animales , Antiinflamatorios/farmacología , Tejido Conectivo/metabolismo , Curcumina/farmacología , Curcumina/uso terapéutico , Diabetes Mellitus Experimental/metabolismo , Modelos Animales de Enfermedad , Encía/efectos de los fármacos , Encía/metabolismo , Masculino , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 8 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Periodontitis/metabolismo , Ratas , Ratas Sprague-Dawley , Piel/efectos de los fármacos , Piel/metabolismo
12.
J Craniofac Surg ; 28(1): 143-146, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27922959

RESUMEN

Pueraria, the root of Pueraria lobata, is a commonly used herb in alternative medicine. This study evaluates the effect of puerarin and autogenous graft material combination on bone regeneration in calvarial critical-sized bone defects. Twenty-four rats were randomly divided into 3 groups of 8 rats each. A 5-mm diameter critical-sized defect was created in the calvarium of each animal. In group C, defects were left unfilled and were allowed to heal spontaneously without the use of any grafting material. Critical-sized bone defect created in animals receiving no treatment. In group ABG, defects were filled with autologous bone graft only. In group P-ABG, defects were filled with autologous bone graft and puerarin combination. All animals were euthanized at 28 days postoperative. Stereologic analyses were performed. New bone area and connective tissue volumes were measured. Stereologic analysis showed that the difference between grafted groups (P-ABG and ABG) and group C was statistically significant with a mean bone formation of 1.13 ±â€Š0.09, 1.11 ±â€Š0.11, and 0.31 ±â€Š0.09 mm respectively (P ≤0.05). The connective tissue volumes were also statistically higher in groups P-ABG and ABG (P ≤0.05). Puerarin has positive effect on new bone formation in autogenous grafted critical-sized bone defects.


Asunto(s)
Regeneración Ósea/efectos de los fármacos , Trasplante Óseo , Isoflavonas/farmacología , Cráneo/efectos de los fármacos , Cráneo/cirugía , Vasodilatadores/farmacología , Animales , Autoinjertos , Tejido Conectivo/efectos de los fármacos , Tejido Conectivo/patología , Masculino , Osteogénesis/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Cráneo/patología , Trasplante Autólogo , Cicatrización de Heridas/efectos de los fármacos
13.
Int J Mol Sci ; 18(8)2017 Aug 22.
Artículo en Inglés | MEDLINE | ID: mdl-28829377

RESUMEN

Cadmium (Cd) is one of the most harmful metals, being toxic to most animal species, including marine invertebrates. Among marine gastropods, the periwinkle (Littorina littorea) in particular can accumulate high amounts of Cd in its midgut gland. In this organ, the metal can elicit extensive cytological and tissue-specific alterations that may reach, depending on the intensity of Cd exposure, from reversible lesions to pathological cellular disruptions. At the same time, Littorina littorea expresses a Cd-specific metallothionein (MT) that, due to its molecular features, expectedly exerts a protective function against the adverse intracellular effects of this metal. The aim of the present study was, therefore, to assess the time course of MT induction in the periwinkle's midgut gland on the one hand, and cellular and tissue-specific alterations in the digestive organ complex (midgut gland and digestive tract) on the other, upon exposure to sub-lethal Cd concentrations (0.25 and 1 mg Cd/L) over 21 days. Depending on the Cd concentrations applied, the beginning of alterations of the assessed parameters followed distinct concentration-dependent and time-dependent patterns, where the timeframe for the onset of the different response reactions became narrower at higher Cd concentrations compared to lower exposure concentrations.


Asunto(s)
Cadmio/administración & dosificación , Cadmio/toxicidad , Fenómenos Fisiológicos del Sistema Digestivo/efectos de los fármacos , Gastrópodos/efectos de los fármacos , Gastrópodos/fisiología , Secuencia de Aminoácidos , Animales , Calcio/metabolismo , Tejido Conectivo/efectos de los fármacos , Tejido Conectivo/metabolismo , Tejido Conectivo/patología , Exposición a Riesgos Ambientales , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patología , Metalotioneína/química , Metalotioneína/genética , Metalotioneína/metabolismo , Polimorfismo de Nucleótido Simple
14.
Beijing Da Xue Xue Bao Yi Xue Ban ; 49(1): 169-75, 2017 02 18.
Artículo en Zh | MEDLINE | ID: mdl-28203026

RESUMEN

OBJECTIVE: To evaluate bone formation in human extraction sockets with absorbed surrounding walls augmented with Bio-Oss and Bio-Gide after a 6-month healing period by histologic and histomorphometric analyses. METHODS: Six fresh molar tooth extraction sockets in 6 patients who required periodontally compromised moral tooth extraction were included in this study. The six fresh extraction sockets were grafted with Bio-Oss particle covered with Bio-Gide. The 2.8 mm×6.0 mm cylindric bone specimens were taken from the graft sites with aid of stent 6 months after the surgery. Histologic and histomorphometric analyses were performed. RESULTS: The histological results showed Bio-Oss particles were easily distinguished from the newly formed bone, small amounts of new bone were formed among the Bio-Oss particles, large amounts of connective tissue were found. Intimate contact between the newly formed bone and the small part of Bio-Oss particles was present. All the biopsy cylinders measurement demonstrated a high inter-individual variability in the percentage of the bone, connective tissues and Bio-Oss particles. The new bone occupied 11.54% (0-28.40%) of the total area; the connective tissues were 53.42% (34.08%-74.59%) and the Bio-Oss particles were 35.04% (13.92%-50.87%). The percentage of the particles, which were in contact with bone tissues, amounted to 20.13% (0-48.50%). CONCLUSION: Sites grafted with Bio-Oss particles covered with Bio-Gide were comprised of connective tissues and small amounts of newly formed bone surrounding the graft particles.


Asunto(s)
Matriz Ósea/anatomía & histología , Matriz Ósea/crecimiento & desarrollo , Colágeno/farmacología , Colágeno/uso terapéutico , Tejido Conectivo/anatomía & histología , Tejido Conectivo/efectos de los fármacos , Tejido Conectivo/crecimiento & desarrollo , Minerales/farmacología , Minerales/uso terapéutico , Alveolo Dental/anatomía & histología , Alveolo Dental/efectos de los fármacos , Alveolo Dental/crecimiento & desarrollo , Matriz Ósea/efectos de los fármacos , Sustitutos de Huesos/uso terapéutico , Humanos , Diente Molar , Osteogénesis/efectos de los fármacos , Osteogénesis/fisiología , Extracción Dental , Alveolo Dental/lesiones , Cicatrización de Heridas/efectos de los fármacos , Cicatrización de Heridas/fisiología
15.
Khirurgiia (Mosk) ; (3): 50-54, 2017.
Artículo en Ruso | MEDLINE | ID: mdl-28374713

RESUMEN

AIM: To study neocollagenogenesis after implantation of polypropylene endoprosthesis and polypropylene combined with polylactic acid endoprosthesis on background of «potassium orotate¼ administration. MATERIAL AND METHODS: We used two different types of endoprosthesis in the experiment. The first type was made of just polypropylene, the second type was made of polypropylene combined with polylactic acid. Histological examination was performed using polarizing microscopy. Collagen types I and III ratio in connective tissue around the prosthesis was analyzed according to the color that was individual for each type. RESULTS: The results were significantly better in case of collagenogenesis stimulation with Potassium orotate within 30 days and later for one type of endoprosthesis. Also we revealed that collagenogenesis and paraprosthesis capsule formation were more active in case of combined endoprosthesis. We revealed stimulating action of «Potassium Orotate¼ for collegenogenesis process, this fact was proved by increased collagen I/III ratio. CONCLUSION: Optimization of collagenogenesis was based on persistent 1,37-fold increase of collagen I/III ratio in case of combined endoprosthesis after 90 days. It was manifested by accelerated formation of connective tissue capsule and facilitated early isolation of the implant from surrounding tissues.


Asunto(s)
Colágeno/metabolismo , Tejido Conectivo , Implantes Experimentales , Ácido Orótico , Poliésteres/farmacología , Polipropilenos/farmacología , Implantación de Prótesis/instrumentación , Regeneración/efectos de los fármacos , Experimentación Animal , Animales , Materiales Biocompatibles/metabolismo , Materiales Biocompatibles/farmacología , Disponibilidad Biológica , Tejido Conectivo/efectos de los fármacos , Tejido Conectivo/metabolismo , Tejido Conectivo/patología , Ratones , Ácido Orótico/metabolismo , Ácido Orótico/farmacología , Compuestos de Potasio/metabolismo , Compuestos de Potasio/farmacología , Implantación de Prótesis/métodos , Regeneración/fisiología
16.
Exerc Sport Sci Rev ; 44(1): 29-36, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26509485

RESUMEN

Exercising individuals commonly consume analgesics, but these medications alter tendon and skeletal muscle connective tissue properties, possibly limiting a person from realizing the full benefits of exercise training. I detail the novel hypothesis that analgesic medications alter connective tissue structure and mechanical properties by modifying fibroblast production of growth factors and matrix enzymes, which are responsible for extracellular matrix remodeling.


Asunto(s)
Analgésicos/farmacología , Tejido Conectivo/efectos de los fármacos , Tejido Conectivo/fisiología , Ejercicio Físico/fisiología , Colágeno/metabolismo , Matriz Extracelular/enzimología , Matriz Extracelular/fisiología , Fibroblastos/metabolismo , Humanos , Péptidos y Proteínas de Señalización Intercelular/biosíntesis , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/fisiología , Tendones/efectos de los fármacos , Tendones/fisiología
17.
J Periodontal Res ; 51(5): 567-76, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26547660

RESUMEN

BACKGROUND AND OBJECTIVE: The use of cyclosporine A induces fibrous enlargement of the gingival connective tissue. Existing treatment modalities, although effective, do not necessarily prevent the recurrence of the lesion. Emerging evidence indicates that tanshinone IIA (Tan IIA) could effectively attenuate a variety of fibrotic diseases. The present research aims to assess whether Tan IIA can effectively alleviate the gingival fibrous overgrowth induced by cyclosporine A. MATERIAL AND METHODS: Forty-five Wistar rats were divided into the no-treatment control group, cyclosporine A-treated group and the group treated with a combination of cyclosporine A and Tan IIA. Paraffin-embedded sections of mandibular first molar regions were selected for hematoxylin and eosin staining, Masson's trichrome staining, picro-sirius red staining and immunohistochemistry analyses of transforming growth factor-ß1 (TGF-ß1), tissue inhibitor of metalloproteinase-1 (TIMP-1) and matrix metalloproteinase-1 (MMP-1). The gingival connective tissue area was measured and numbers of the TGF-ß1-, TIMP-1- and MMP-1-positive cells were counted. The analysis of variance for factorial designs for testing the overall differences and Fisher least significant difference test for post hoc analysis were used to determine the significance levels. RESULTS: Cyclosporine A treatment led to overgrowth of gingival connective tissue in rats. In the cyclosporine A-treated rats, the expression of TGF-ß1 and TIMP-1 was significantly upregulated, whereas expression of the MMP-1 was downregulated, along with thicker and denser collagen fibers. In rats treated with a combination of cyclosporine A and Tan IIA, the cyclosporine A-induced changes were alleviated. CONCLUSIONS: Cyclosporine A enhanced gingival fibrous overgrowth via upregulation of the TGF-ß1 and TIMP-1 expression, and downregulation of MMP-1 expression. Tan IIA can effectively prevent cyclosporine A-induced gingival fibrous overgrowth in rats by downregulating TGF-ß1 and TIMP-1 expression, and upregulating MMP-1 expression.


Asunto(s)
Abietanos/farmacología , Tejido Conectivo/efectos de los fármacos , Ciclosporina/farmacología , Sobrecrecimiento Gingival/tratamiento farmacológico , Animales , Tejido Conectivo/patología , Encía/efectos de los fármacos , Encía/patología , Inmunohistoquímica , Masculino , Mandíbula , Metaloproteinasa 1 de la Matriz/análisis , Metaloproteinasa 1 de la Matriz/metabolismo , Diente Molar , Ratas , Ratas Wistar , Inhibidor Tisular de Metaloproteinasa-1/análisis , Inhibidor Tisular de Metaloproteinasa-1/metabolismo , Factor de Crecimiento Transformador beta1/análisis , Factor de Crecimiento Transformador beta1/metabolismo
18.
Platelets ; 27(8): 771-776, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27255378

RESUMEN

Numerous bioactive growth factors and cytokines in platelet-rich plasma (PRP) have recently made it an attractive biomaterial for therapeutic purposes. These growth factors have the potential to regenerate the injured tissues. The aim of this study was to investigate the therapeutic effects of PRP in hepatotoxic animal model. Hepatotoxicity was induced in rats by oral administration of 4 mL/kg/week of CCl4 diluted 1:1 in corn oil for 10 weeks. To confirm the hepatotoxicity, 24 h after the last CCl4 administration, blood samples were collected via cardiac puncture to assess the serum levels of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, albumin, total protein, and total bilirubin. Twenty-four hours after blood collection, the experimental animals received a single injection of PRP (1 mL) via the anterior mesenteric vein. One week later, all biochemical tests were performed again, and the rats were scarified and their livers were removed, prepared histologically, and stained. The stereological analyses were performed to evaluate the effects of PRP on histopathological features of CCl4-treated livers. The results were compared statistically with the corresponding control and CCl4+normal saline (NS)-treated animals. A significant decrease in the number and volume of hepatocytes (p = 0.01), and also a reduction in the volume of sinusoids (p = 0.001) and connective tissue (p = 0.04), were observed in the PRP-treated animals compared with the CCl4+NS-treated ones. Our findings demonstrated that application of PRP had beneficial effects on CCl4-induced fibrosis; however, it had detrimental effects on the total number of hepatocytes and the volume of hepatocytes and sinusoidal spaces.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/terapia , Regeneración Hepática , Plasma Rico en Plaquetas , Animales , Tetracloruro de Carbono/toxicidad , Enfermedad Hepática Inducida por Sustancias y Drogas/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/diagnóstico , Tejido Conectivo/efectos de los fármacos , Tejido Conectivo/patología , Modelos Animales de Enfermedad , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Hepatocitos/patología , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Pruebas de Función Hepática , Masculino , Tamaño de los Órganos , Recuento de Plaquetas , Ratas , Resultado del Tratamiento
19.
Acta Odontol Scand ; 74(7): 558-564, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27538770

RESUMEN

OBJECTIVE: We aimed to determine the clinical effects of titanium-prepared, platelet-rich fibrin (T-PRF) on human palatal mucosal wound healing (PMWH) and to identify its effect on time-dependent changes in palatal soft-tissue thickness (PSTT) in terms of histoconduction, which is a new concept. MATERIALS AND METHODS: Free gingival graft (FGG) donor sites were treated with T-PRF and compared with an untreated control group. The results of colour match and H2O2-bubbling tests for complete wound epithelization (CWE) were recorded on days 3, 7, 14 and 21. Pain level, number of analgesics used and bleeding status were recorded for the first 7 days. PSTT was measured at baseline and after 1 and 6 months. RESULTS: Colour match scores of the test group were significantly higher than those of the control group at 7 and 14 days. CWE was observed at a higher frequency in the test group than in the control group on day 14. Post-operative bleeding prevalence was lower in the test group than in the control group for the first 2 days. A time-dependent decrease in PSTT was observed at 1 and 6 months in the control group compared with baseline (baseline, 4.23 ± 0.62 mm; 1 month, 4.01 ± 0.68 mm; and 6 months, 3.93 ± 0.69 mm). However, no significant difference was found in the test group (baseline, 4.29 ± 0.64 mm; 1 month, 4.61 ± 0.51 mm; and 6 months, 4.51 ± 0.58 mm). CONCLUSION: The T-PRF membrane exhibited positive effects on PMWH. T-PRF, which is a promising autogenous matrix for histoconduction, may also be preferred as an autogenous alternative to connective tissue grafts in the treatment of gingival recessions and peri-implant mucosal recessions.


Asunto(s)
Materiales Biocompatibles/química , Plaquetas/fisiología , Fibrina/uso terapéutico , Encía/trasplante , Titanio/química , Sitio Donante de Trasplante/patología , Analgésicos/uso terapéutico , Color , Tejido Conectivo/efectos de los fármacos , Tejido Conectivo/patología , Tejido Conectivo/trasplante , Estudios de Seguimiento , Encía/efectos de los fármacos , Encía/patología , Recesión Gingival/cirugía , Humanos , Peróxido de Hidrógeno/administración & dosificación , Hemorragia Bucal/clasificación , Oxidantes/administración & dosificación , Dimensión del Dolor/métodos , Dolor Postoperatorio/prevención & control , Hueso Paladar/cirugía , Hemorragia Posoperatoria/clasificación , Estudios Prospectivos , Repitelización/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos
20.
Klin Lab Diagn ; 61(2): 103-6, 2016 Feb.
Artículo en Ruso | MEDLINE | ID: mdl-27455564

RESUMEN

The recent studies of molecular physiology of fibrillin and pathophysiology of inherent disorders of structure and function of connective tissue such as dissection and aneurysm of aorta, myxomatously altered cusps and prolapses of mitral valve, syndrome of hyper-mobility of joints, demonstrated that important role in development of these malformations play alterations of transfer of signals by growth factors and matrix cellular interaction. These conditions under manifesting Marfan's syndrome can be a consequence of anomalies of fibrillin-1 which deficiency unbrakes process of activation of transforming growth factor-ß (TGFß). The involvement of TGFß in pathogenesis of Marfan's syndrome permits consider antagonists of angiotensin-transforming enzymes as potential pharmaceuticals in therapy of this disease. The article presents analysis of publications' data related to this problem.


Asunto(s)
Aneurisma de la Aorta/inmunología , Disección Aórtica/inmunología , Inestabilidad de la Articulación/inmunología , Síndrome de Marfan/inmunología , Prolapso de la Válvula Mitral/inmunología , Factor de Crecimiento Transformador beta/inmunología , Disección Aórtica/tratamiento farmacológico , Disección Aórtica/genética , Disección Aórtica/patología , Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Aneurisma de la Aorta/tratamiento farmacológico , Aneurisma de la Aorta/genética , Aneurisma de la Aorta/patología , Tejido Conectivo/efectos de los fármacos , Tejido Conectivo/inmunología , Tejido Conectivo/patología , Fibrilina-1 , Fibrilinas , Regulación de la Expresión Génica , Humanos , Inestabilidad de la Articulación/tratamiento farmacológico , Inestabilidad de la Articulación/genética , Inestabilidad de la Articulación/patología , Síndrome de Marfan/tratamiento farmacológico , Síndrome de Marfan/genética , Síndrome de Marfan/patología , Proteínas de Microfilamentos/genética , Proteínas de Microfilamentos/inmunología , Prolapso de la Válvula Mitral/tratamiento farmacológico , Prolapso de la Válvula Mitral/genética , Prolapso de la Válvula Mitral/patología , Peptidil-Dipeptidasa A/genética , Peptidil-Dipeptidasa A/inmunología , Transducción de Señal , Factor de Crecimiento Transformador beta/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA